Study of Pelabresib add-on to Ruxolitinib in Japanese Adult Patients With Myelofibrosis

Clinical trial NCT07340138 · RECRUITING

Trial details

NCT number: NCT07340138
Sponsor: Novartis Pharmaceuticals
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Primary Myelofibrosis (PMF)Post-polycythemia Vera Myelofibrosis (Post-PV MF)Post-essential Thrombocythemia Myelofibrosis (Post-ET MF)

Start date: 2026-04-15
Primary completion: 2026-11-16
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.